Have a personal or library account? Click to login

Serological, clinical and epidemiological aspects of Lyme borreliosis in Mures County, Romania

Revista Romana de Medicina de Laborator
Volume 22 (2014): Issue 2 (June 2014)
By:
Open Access
|Jun 2014

References

  1. 1. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definition for diagnosis and management in Europe. Clin Microbiol Infect. 2011 Jan;17(1):69-79 DOI: 10.1111/j.1469-0691.2010.03175.x10.1111/j.1469-0691.2010.03175.x20132258
    Search in Google Scholar
  2. 2. Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and Management of Lyme disease. Am Fam Physician. 2012 Jun 1; 85(11):1086-93
    Search in Google Scholar
  3. 3. Wormser GP, Brisson D, Liveris D, Hanincora K, Sandigursky S, et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis. 2008 Nov 1;198(9):1358-64 DOI: 10.1086/59227910.1086/592279277673418781866
    Search in Google Scholar
  4. 4. Wormser GP, Dattwyler RJ, Shapirro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov 1;43(9):1089-134 DOI: 10.1086/50866710.1086/50866717029130
    Search in Google Scholar
  5. 5. Coipan EC, Vladimirescu AF: Ixodes ricinus ticks (Acari: Ixodidae): vectors for Lyme disease spirochetes in Romania. Exp Appl Acarol. 2011 Jul;54(3):293-300 DOI: 10.1007/s10493-011-9438-410.1007/s10493-011-9438-421431930
    Search in Google Scholar
  6. 6. Lindgren E, Jaenson TGT: Lyme borreliosis in Europe. Influences of climate and climate change, epidemiology, ecology and adaptation measures, World Health Organization, Regional Office for Europe, Copenhagen, Denmark. 2006;5-24 [http://www.euro.who.int/__data/ assets/pdf_file/0006/96819/E89522.pdf]
    Search in Google Scholar
  7. 7. European Concerted Action on Lyme Borreliosis. Diagnosis: Case Definition EUCALB: [http://eucalb.com/]
    Search in Google Scholar
  8. 8. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49(1):13-21. Review DOI: 10.1111/j.1574-695X.2006.00139.x10.1111/j.1574-695X.2006.00139.x17266710
    Search in Google Scholar
  9. 9. Centrul Național de Supraveghere şi Control al Bolilor Transmisibile - Boala Lyme - metodologie de supraveghere: Lyme borreliosis. [http://www.insp.gov. ro/cnscbt/index.php?option=com_docman&task=cat_ view&gid=34&Itemid=10] [in Romanian]
    Search in Google Scholar
  10. 10. Centers for Disease Control and Prevention United States: Effect of electronic laboratory reporting on the burden of Lyme disease surveillance: New Jersey, 2001-2006. MMWR. 2008 Jan;57(2):42-5
    Search in Google Scholar
  11. 11. Hristea A, Hristescu S, Ciufecu C, Vasile A: Seroprevalence of Borrelia burgorferi in Romania. Eur J Epidemiol. 2001;17(9):891-6 DOI: 10.1023/A:101560072990010.1023/A:1015600729900
    Search in Google Scholar
  12. 12. Semenza JC, Suk JE, Estevez V, Ebi KL, Lindgren E. Mapping Climate Change Vulnerabilities to Infectious Disease in Europe. Environ Health Perspect. 2012 Mar;120(3):385-92 DOI: 10.1289/ehp.110380510.1289/ehp.1103805329534822113877
    Search in Google Scholar
  13. 13. Stanek G, Strle F. Lyme borreliosis: a European perspective ondiagnosis and clinical management. Curr Opin Infect Dis. 2009 Oct;22(5):450-4 DOI: 10.1097/ QCO.0b013e32832ee88010.1097/QCO.0b013e32832ee88019571749
    Search in Google Scholar
  14. 14. Rizzoli A, Hauffe HC, Carpi G, Vourch GI, Neseler M, Rosa R. Lyme borreliosis in Europe. Eurosurveillance. 2011 Jul;16(27):1-610.2807/ese.16.27.19906-en
    Search in Google Scholar
  15. 15. Halperin JJ, Shapiro ED, Logigian EL, Belman AL, Dotevall L, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007 Jul;69(1):91-102 DOI: 10.1212/01. wnl.0000265517.66976.28
    Search in Google Scholar
  16. 16. Țilea B, Chiriac C, Țilea I, Urcan R, Tripon G, Gliga M. Diagnostic, therapeutic and evolutive particularities of Lyme disease. Rev Romana Med Lab. 2009 Jun;15(2):55-60
    Search in Google Scholar
  17. 17. O’Connel S. Lyme borreliosis: current issues in diagnosis and management. Curr Opin Infect Dis. 2010 Jun;23(3):231-5 DOI: 10.1097/ QCO.0b013e32833890e210.1097/QCO.0b013e32833890e220407371
    Search in Google Scholar
  18. 18. Ljostad U, Skogvoll E, Eikeland R, Skarpaas T, et al. Oral doxycycline versus intravenous ceftriaxon for European Lyme neuroborreliosis: a multricentric, non-inferiority, double blind, randomised trial. Lancet Neurol. 2008 Aug;7(8):690-5 DOI: 10.1016/S1474-4422(08)70119-410.1016/S1474-4422(08)70119-4
    Search in Google Scholar
  19. 19. Smith R, Takkinnen J. Lyme borreliosis: Europe-wide coordinated surveillance and action nedeed? Euro Surveill. 2006 Jun;11(6):E060622.110.2807/esw.11.25.02977-en16819127
    Search in Google Scholar
  20. 20. Skogman BH, Glimåker K, Nordwall M, Vrethem M, Ödkvist L, Forsberg P. Long-term clinical outcome after Lyme neuroborreliosis in childhood. Pediatrics. 2012 Aug;130(2):262-9 DOI: 10.1542/peds.2011-371910.1542/peds.2011-371922802606
    Search in Google Scholar
  21. 21. Albrecht P, Henke N, Lehmann HC, Macht S, Hefter H et al. A case of relapsing -remitting neuroborreliosis? Challenges in the differential diagnosis of recurrent myelitis. Case Rep Neurol. 2012 Jan;4(1):47-53 DOI: 10.1159/00033722310.1159/000337223336230222649342
    Search in Google Scholar
  22. 22. Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. Neurobiol Dis. 2010 Mar;37(3):534-41. DOI: 10.1016/j.nbd.2009.11.01610.1016/j.nbd.2009.11.01619944760
    Search in Google Scholar
  23. 23. Wormser GP, Nadelman RB, Schwartz I.The amber theory of Lyme arthritis: initial description and clinical implications. Clin Reumatol. 2012 Jun;31(6):989-94 DOI: 10.1007/s10067-012-1964-x10.1007/s10067-012-1964-x22411576
    Search in Google Scholar
  24. 24. Puius YA, Kalish RA. Lyme arthritis: pathogenesis, clinical presentation, and management. Infect Dis North Am. 2008 Jun;22(2):289-300 DOI: 10.1016/j. idc.2007.12.014
    Search in Google Scholar
  25. 25. Costello JM, Alexander ME, Greco KM, Perez AR, Laussen PC. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics. 2009 May;123(5):835-41 DOI: 10.1542/peds.2008-305810.1542/peds.2008-305819403477
    Search in Google Scholar
  26. 26. Lo R, Meuzies DJ, Archer H, Cohen TJ.J.Complete heart block due to Lyme carditis: Invasive Cardiol. 2003 Jun;15(6):367-9
    Search in Google Scholar
  27. 27. Koene R, Boulware DR, Kemperman M, Konety SH, Groth M, et al. Acute hearth failure from lyme carditis. Circ Heart Fail. 2012 Mar;5(2):e24-6 DOI: 10.1161/ CIRCHEARTFAILURE.111.96553310.1161/CIRCHEARTFAILURE.111.965533331105322438525
    Search in Google Scholar
DOI: https://doi.org/10.2478/rrlm-2014-0020 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 233 - 244
Submitted on: Oct 18, 2013
Accepted on: May 16, 2014
Published on: Jun 21, 2014
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Lyme borreliosis,
serology,
epidemiology,
clinical aspects,
Romania
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2014 Brîndușa Țilea, Grațiela Tripon, Septimiu Voidăzan, Ioan Țilea, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 22 (2014): Issue 2 (June 2014)Next article